title: [Rate and rhythm control in atrial fibrillation : pharmacological approaches].
abstract: Atrial fibrillation is the most common form of cardiac arrhythmia, occurring in 1-2 % of the population and due to an increased life expectancy the prevalence will increase further. Pharmacological treatment of atrial fibrillation is an important component of basic initial therapeutic options for patients with atrial fibrillation. Independent of an individually adjusted prevention of thromboembolism, rate and rhythm management can also be carried out. While rate control mainly applies to all patients, rhythm control is only indicated in patients who remain clinically symptomatic despite sufficient rate control. Profound knowledge about antiarrhythmic drugs including specific interactions is necessary due to the variable individual effects and sometimes severe side effects.
authors: Medizinische Klinik I - Kardiologie, Universitätsklinik Gießen, Klinikstr. 33, 35392, Gießen, Deutschland, kweipert@gmx.de.
authors: K F
authors: KF
authors: Weipert
authors: D
authors: D
authors: Erkapic
authors: J
authors: J
authors: Schmitt
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000175:diagnosis* / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods*; D004562:Electrocardiography / Q000187:drug effects*; D006801:Humans; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents